PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Using gold and light to study molecules in water

Researchers at EPFL can now observe biomolecule interactions in a sample of water in real time; A major step for medicine

2013-07-31
(Press-News.org) Thanks to a new device that is the size of a human hair, it is now possible to detect molecules in a liquid solution and observe their interactions. This is of major interest for the scientific community, as there is currently no reliable way of examining both the behavior and the chemical structure of molecules in a liquid in real time.

Developed at Boston University by Hatice Altug and her student Ronen Adato, the process brings together infrared detection techniques and gold nanoparticles. It could potentially make a whole new class of measurements possible, which would be a critical step in understanding basic biological functions as well as key aspects of disease progression and treatment. "Our technology could prove useful for studying the behaviour of proteins, medicines and cells in the blood or pollutants in water", says Hatice Altug.

Now a researcher at EPFL Dr. Altug has had her results published in Nature Communications.

Like a guitar string

The device is based on a well-known detection technique called infrared absorption spectroscopy. Infrared light can already be used to detect elements: The beam excites the molecules, which start to vibrate in different ways depending on their size, composition and other properties. "It's like a guitar string vibrating differently depending on its length," explains Hatice Altug. The unique vibration of each type of molecule acts as a signature for that molecule.

This technique works very well in dry environments but not at all well in aqueous environments. "A large number of molecules need to be present for them to be detected. It's also more difficult to detect molecules in water, as when the beam goes through the solution, the water molecules vibrate as well and interfere with the target molecule's signature," explains Dr. Altug.

Using nanoparticles to capture and illuminate molecules

To get around these obstacles, the researchers have developed a system capable of isolating the target molecules and eliminating interferences.

The size of a penny, the device is made up of miniature fluidic chambers, which are covered on one side with nano-scale gold particles with surprising properties. "We cover the surface of the nanoparticles with, for example, antibodies, in order to make a specific protein or chemical stick to them," explains the researcher. "Once the solution containing the targeted elements is introduced into the chamber, the nanoparticles act as molecule catchers." This technique makes it possible to isolate the target molecules from the rest of the liquid.

But this is not the only role the nanoparticles play. They are also capable of concentrating light in nanometer-size volumes around their surface as a result of plasmonic resonance.

In the chamber, the beam doesn't need to pass through the whole solution. Instead, it is sent straight to the nanoparticle, which concentrates the light. Caught in the trap, the target molecules are the only ones that are so intensely exposed to the photons.

The reaction between the molecules and the infrared photons is extremely strong, which means they can be detected and observed very precisely. "This technique enables us to observe molecules in-situ as they react with elements in their natural environment. This could prove extremely useful for both medicine and biology," states Dr. Altug.

Use in medical research

Another advantage is that the chip is extremely compact and can be connected to microscopes already in use. "We don't need large sample sizes to conduct our analyses," says Ronen Adato.

Going forward, Hatice Altug intends to continue her research with a focus on medical applications. The first tests have been conducted with ordinary antibody molecules, and the analyses now need to be fine-tuned. "I'd really like to work with other life-science researchers, hospitals and biologists. I'm especially interested in using my method in the study of diseases, including cancer and neurological disorders, to observe the effect of certain medicines on diseased cells or to detect disease biomarkers, for example."



INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

Electrified sewage: New American Chemical Society video on electricity from wastewater

2013-07-31
Shocking as it may seem, wastewater flushed down toilets and sinks is getting a new life thanks to special fuel cells that use it to produce electricity, according to the latest video in the American Chemical Society's (ACS') Bytesize Science series. Produced by the world's largest scientific society, the video is at http://www.BytesizeScience.com. Bruce E. Logan, Ph.D., featured in the video, points out that sewage treatment traditionally has been a big consumer of electricity. With the new fuel cells, that situation could be reversed, with sewage becoming the raw material ...

New therapy improves life span in melanoma patients with brain metastases, SLU researchers find

2013-07-31
ST. LOUIS -- In a retrospective study, Saint Louis University researchers have found that patients with melanoma brain metastases can be treated with large doses of interleukin-2 (HD IL-2), a therapy that triggers the body's own immune system to destroy the cancer cells. The study that was recently published in Chemotherapy Research and Practice, reviews cases of eight patients who underwent this therapy at Saint Louis University. John Richart, M.D., associate professor of internal medicine at SLU and principal investigator of the study, first treated a patient with ...

Cross-country collaboration leads to new leukemia model

2013-07-31
Eight years ago, two former Stanford University postdoctoral fellows, one of them still in California and the other at the Harvard Stem Cell Institute (HSCI) in Cambridge, began exchanging theories about why patients with leukemia stop producing healthy blood cells. What was it, they asked, that caused bone marrow to stop producing normal blood-producing cells? And after almost a decade of bicoastal collaboration, Emmanuelle Passegué, now a professor in the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at the University of California, San ...

Brain maps to benefit epileptic surgery

2013-07-31
A brain imaging research team led by Simon Fraser University neuroscientist Dr. Ryan D'Arcy has found a new way to help surgeons more accurately plan for surgical treatment in epilepsy. The results of a recent study using magnetoencephalography (MEG) have been published in the field's highest impact journal, Human Brain Mapping. To showcase the study, the journal highlighted the novel images of MEG activity on the August 2013 cover. D'Arcy and his team used MEG technology to produce detailed spatial maps of critical language functions in order to better enable pre-operative ...

Genetic link to gestational diabetes

2013-07-31
CHICAGO --- New Northwestern Medicine® research on the genetics of diabetes could one day help women know their risk for developing gestational diabetes before they become pregnant -- and lead to preventive measures to protect the health of offspring. Gestational diabetes affects 18 percent of pregnancies but usually disappears when a pregnancy is over. Babies born to women with gestational diabetes are typically larger at birth, which can lead to complications during delivery. They are at an increased risk of developing metabolic diseases, such as diabetes, in childhood ...

Oregon lab changes game for synthesizing new materials

2013-07-31
EUGENE, Ore. -- University of Oregon chemist David C. Johnson likens his lab's newly published accomplishments to combining two flavors of ice cream -- vanilla and chocolate -- and churning out thousands of flavors to appeal to any taste bud. In reality, though, he is referring to his game-changing approach to synthesize thousands of new compounds with ultra low thermal conductivity and other unusual properties quickly instead of the traditional and time-consuming preparative approach that is limited to just a few thermodynamically stable compounds. In a paper placed ...

HIV answers raise new ethical questions

2013-07-31
The Food and Drug Administration's approval last year of the drug Truvada for prevention of HIV infection was a milestone in the fight against HIV/AIDS, but experts are cautioning that it is only the beginning of new ethical concerns for health care professionals, policy makers, researchers and those taking Truvada to prevent HIV infection. "For the first time, we will have a large number of individuals who are not infected with HIV taking medication for HIV, which introduces ethical concerns of well-being and justice," says Jeremy Sugarman, Deputy Director for Medicine ...

Berkeley Lab researchers discover universal law for light absorption in 2D semiconductors

2013-07-31
From solar cells to optoelectronic sensors to lasers and imaging devices, many of today's semiconductor technologies hinge upon the absorption of light. Absorption is especially critical for nano-sized structures at the interface between two energy barriers called quantum wells, in which the movement of charge carriers is confined to two-dimensions. Now, for the first time, a simple law of light absorption for 2D semiconductors has been demonstrated. Working with ultrathin membranes of the semiconductor indium arsenide, a team of researchers with the U.S. Department of ...

Navy turns to UAVs for help with radar, communications

2013-07-31
ARLINGTON, Va.—Scientists recently launched unmanned aerial vehicles (UAVs) from a research vessel in a significant experiment that could help boost the Navy's radar and communications performance at sea. Sailing off Virginia Beach, Va., from July 13 to 18, the Office of Naval Research's (ONR) Research Vessel (R/V) Knorr explored ocean and atmospheric weather variations that can change the angle that radar and radio waves bend, making it more difficult for ships to remain undetected and hindering their ability to communicate or locate adversaries. Sponsored by ONR's ...

Penn: New variants at gene linked to kidney disease, sleeping sickness resistance

2013-07-31
A new study led by University of Pennsylvania researchers involves a classic case of evolution's fickle nature: a genetic mutation that protects against a potentially fatal infectious disease also appears to increase the risk of developing a chronic, debilitating condition. Such a relationship exists between malaria and sickle cell anemia. Individuals who carry a gene to resist the former are carriers for the latter. And recently scientific evidence has suggested that individuals who are resistant to human African trypanosomiasis, or sleeping sickness, are predisposed ...

LAST 30 PRESS RELEASES:

Coronary artery calcium may be a predictor for all-cause mortality, including medical conditions not related to heart health

Minimally invasive coronary calcium CT scans used to determine heart disease risk are effective at finding other potential health problems

High-impact clinical trials generate promising results for improving kidney health - part 3

Mass General Brigham researchers find PCSK9 inhibitor reduced risk of first heart attack, stroke

Triglyceride-lowering drug significantly reduced rate of acute pancreatitis in high-risk patients

Steatotic liver disease and cancer: From pathogenesis to therapeutic frontiers

SGLT2 inhibitors and kidney outcomes by glomerular filtration rate and albuminuria

Comprehensive analysis supports routine use of metabolic drug for people with all levels of kidney function

Temporary benefit for immune system in early HIV treatment, but dysregulation returns

Chronic kidney disease is now the ninth leading cause of death

Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide

Participant experiences in a kidney failure care intervention in the navigate-kidney study

Community health worker support for Hispanic and Latino individuals receiving hemodialysis

Scientists unveil new strategies to balance farming and ecological protection in Northeast China

UT Health San Antonio scientist helps shape new traumatic brain injury guidelines

Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands

Study uncovers glomerular disease outcomes across the lifespan

Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats

Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering

A husband’s self-esteem may protect against preterm births, study finds

Michigan State University's James Madison College receives over $1 million to launch civic education academy

White paper on recovering from burnout through mentoring released by University of Phoenix College of Doctoral Studies

Defunct Pennsylvania oil and gas wells may leak methane, metals into water

Kessler Foundation’s John DeLuca, PhD, honored with Reitan Clinical Excellence Award from National Academy of Neuropsychology

Discordance in creatinine- and cystatin C–based eGFR and clinical outcomes

Disagreement between two kidney function tests predicts serious health problems

American College of Cardiology, OpenEvidence to advance AI-enabled, evidence-based cardiovascular care

OHSU researchers develop promising drug for aggressive breast cancer

Evaluating the potential of a sleep intervention among youth at high-risk for borderline personality disorder

Saturn’s icy moon may host a stable ocean fit for life, study finds

[Press-News.org] Using gold and light to study molecules in water
Researchers at EPFL can now observe biomolecule interactions in a sample of water in real time; A major step for medicine